摘要
胰岛素样生长因子(insulin-like growth factor,IGF)-Ⅱ/IGFⅡ-ⅠR相关信号通路与肝细胞癌(hepatocellular carcinoma,HCC)发生发展密切相关.IGF-Ⅱ活化可经IGF-ⅠR传递促有丝分裂信号,增加HCC变可能.近来研究显示靶向IGF-Ⅱ或IGF-ⅠR可明显抑制HCC细胞增殖.本文就IGF-Ⅱ和IGF-ⅠR信号通路在肝细胞癌变、转化过程中的作用及作为HCC基因治疗靶目标的研究进展进行了评述.
The insulin-like growth factor (IGF)-Ⅱ/IGF-Ⅰreceptor (IGF-ⅠR) related signaling pathway is associated with the development and progression of hepatocellular carcinoma (HCC). Hepatic IGF-Ⅱactivation can deliver a mitogenic signal to IGF-ⅠR to increase the tumorigenic potential of liver cells. Recently, a considerable amount of evidence suggests that targeted inhibition of IGF-Ⅱ and IGF-ⅠR could inhibit the proliferation of hepatoma cells. In this review, we summarize the interaction of IGF-Ⅱ and IGF-ⅠR in hepatocarcinogenesis and evaluate their potential use in molecular targeted therapy for hepatocellular carcinoma.
出处
《世界华人消化杂志》
CAS
北大核心
2011年第29期3009-3014,共6页
World Chinese Journal of Digestology
基金
江苏省自然科学基金资助项目
No.BK2008187~~